The high affinity between Ang and low-density lipoprotein receptor-related protein-1 enabled EVs to cross the BBB, and the cell-penetrating ability of TAT breached the blood-brain tumor barrier (BBTB), thus improving the efficacy of chemotherapeutic molecules for brain tumors. The gene discussed is LRP1; the disease is brain neoplasm.